Anne-Floor B E Quast1, Vincent F van Dijk2, Sing-Chien Yap3, Alexander H Maass4, Lucas V A Boersma2, Dominic A Theuns3, Reinoud E Knops1. 1. Heart Center, Department of Clinical and Experimental Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. 2. Department of Cardiology, St Antonius Hospital, Nieuwegein, the Netherlands. 3. Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands. 4. Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Abstract
INTRODUCTION: Experience with the subcutaneous implantable cardioverter-defibrillator (S-ICD) is expanding rapidly. However, data on long-term performance or complications related to elective generator replacement are lacking. METHODS: Follow-up (FU) data of all patients implanted between December 2008 and April 2011 were collected. Complications were defined as those requiring surgical intervention. Kaplan-Meier estimates for complication and shock rates, with corresponding 95% confidence intervals (CI), were calculated. RESULTS: One hundred and eighteen patients were included. Median FU was 6.1 years (IQR 5.6-6.5 years). Short-term complication rate (0-30 days) was 3% (CI 0-6%). Long-term complication rate at 6 years was 19% (CI 12-26%), corresponding with an annual complication rate of 3%. One patient in this cohort developed a need for a transvenous ICD (TV-ICD) in order to provide pacing for bradycardia (1%). Six patients were implanted with a TV-ICD after experiencing an S-ICD complication for which extraction was necessary. In total, 10 S-ICDs were extracted; none resulted in a complication. Eight patients had a nonsystemic ICD-related infection and no lead failures were observed. The majority, 68 (58%) patients, received an elective generator replacement. Two patients had a complication related to generator replacement (3%). Battery longevity was 5.6 years (IQR 5.2-6.1). Appropriate and inappropriate shock rates of 6-year estimates were 17% (CI 9-25%) and 21% (CI 15-27%), respectively. CONCLUSIONS: This cohort represents the longest follow-up to date and shows a low annual complication rate without lead failures or systemic infections. Battery longevity of the first S-ICD generation results in relative early generator replacement procedures.
INTRODUCTION: Experience with the subcutaneous implantable cardioverter-defibrillator (S-ICD) is expanding rapidly. However, data on long-term performance or complications related to elective generator replacement are lacking. METHODS: Follow-up (FU) data of all patients implanted between December 2008 and April 2011 were collected. Complications were defined as those requiring surgical intervention. Kaplan-Meier estimates for complication and shock rates, with corresponding 95% confidence intervals (CI), were calculated. RESULTS: One hundred and eighteen patients were included. Median FU was 6.1 years (IQR 5.6-6.5 years). Short-term complication rate (0-30 days) was 3% (CI 0-6%). Long-term complication rate at 6 years was 19% (CI 12-26%), corresponding with an annual complication rate of 3%. One patient in this cohort developed a need for a transvenous ICD (TV-ICD) in order to provide pacing for bradycardia (1%). Six patients were implanted with a TV-ICD after experiencing an S-ICD complication for which extraction was necessary. In total, 10 S-ICDs were extracted; none resulted in a complication. Eight patients had a nonsystemic ICD-related infection and no lead failures were observed. The majority, 68 (58%) patients, received an elective generator replacement. Two patients had a complication related to generator replacement (3%). Battery longevity was 5.6 years (IQR 5.2-6.1). Appropriate and inappropriate shock rates of 6-year estimates were 17% (CI 9-25%) and 21% (CI 15-27%), respectively. CONCLUSIONS: This cohort represents the longest follow-up to date and shows a low annual complication rate without lead failures or systemic infections. Battery longevity of the first S-ICD generation results in relative early generator replacement procedures.
Authors: Kevin Willy; Markus Bettin; Florian Reinke; Nils Bögeholz; Christian Ellermann; Benjamin Rath; Patrick Leitz; Julia Köbe; Lars Eckardt; Gerrit Frommeyer Journal: Clin Res Cardiol Date: 2019-03-21 Impact factor: 5.460
Authors: Larry M Baddour; Raul Weiss; George E Mark; Mikhael F El-Chami; Mauro Biffi; Vincent Probst; Pier D Lambiase; Marc A Miller; Timothy McClernon; Linda K Hansen; Bradley P Knight Journal: Pacing Clin Electrophysiol Date: 2020-04-23 Impact factor: 1.976
Authors: Willeke van der Stuijt; Anne-Floor B E Quast; Sarah W E Baalman; Koen C de Wilde; Tom F Brouwer; Arthur A M Wilde; Reinoud E Knops Journal: Europace Date: 2021-03-08 Impact factor: 5.214
Authors: M L Narducci; R Scacciavillani; G Pinnacchio; G Bencardino; F Perna; G Comerci; M Campisi; I Ceccarelli; C Pavone; F Spera; A Bisignani; F Crea; G Pelargonio Journal: Int J Cardiol Heart Vasc Date: 2021-07-20